Increased anxiety-like behavior during the post-stress period in mice exposed to repeated restraint stress

Hormones and Behavior

Volumn 50, Issue 3, 2006, Pages 489-495

  Chotiwat, Christina ^a   Harris, Ruth B S ^a  

^a UNIVERSITY OF GEORGIA   (United States)

Author keywords

Corticosterone; Defensive withdrawal; Elevated plus maze; Light dark box; Marble burying

Indexed keywords

CORTICOSTERONE;

ANIMAL EXPERIMENT; ANXIETY; ARTICLE; CONTROLLED STUDY; ENDOCRINE FUNCTION; EVALUATION; HORMONE RELEASE; LIGHT DARK CYCLE; MALE; MAZE TEST; MOUSE; NONHUMAN; PRIORITY JOURNAL; STRESS; WEIGHT REDUCTION;

ANALYSIS OF VARIANCE; ANIMALS; ANXIETY; BODY WEIGHT; CORTICOSTERONE; DISEASE MODELS, ANIMAL; EXPLORATORY BEHAVIOR; MALE; MICE; RESTRAINT, PHYSICAL; SEVERITY OF ILLNESS INDEX; STRESS, PSYCHOLOGICAL;

EID: 33747067119     PISSN: 0018506X     EISSN: 10956867     Source Type: Journal    
DOI: 10.1016/j.yhbeh.2006.06.007     Document Type: Article

References (39)

1. Adamec R.E., and Shallow T. Lasting effects on rodent anxiety of a single exposure to a cat. Physiol. Behav. 54 1 (1993) 101-109
2. Buwalda B., de Boer S.F., Van Kalkeren A.A., and Koolhaas J.M. Physiological and behavioral effects of chronic intracerebroventricular infusion of corticotropin-releasing factor in the rat. Psychoneuroendocrinology 22 5 (1997) 297-309
3. Caggiula A.R., Antelman S.M., Aul E., Knopf S., and Edwards D.J. Prior stress attenuates the analgesic response but sensitizes the corticosterone and cortical dopamine responses to stress 10 days later. Psychopharmacology (Berlin) 99 2 (1989) 233-237
4. Carrasco G.A., and Van de Kar L.D. Neuroendocrine pharmacology of stress. Eur. J. Pharmacol. 463 1-3 (2003) 235-272
5. Cook C.J. Stress induces CRF release in the paraventricular nucleus, and both CRF and GABA release in the amygdala. Physiol. Behav. 82 4 (2004) 751-762
6. Costall B., Jones B.J., Kelly M.E., Naylor R.J., and Tomkins D.M. Exploration of mice in a black and white test box: validation as a model of anxiety. Pharmacol. Biochem. Behav. 32 3 (1989) 777-785
7. Curtis A.L., Lechner S.M., Pavcovich L.A., and Valentino R.J. Activation of the locus coeruleus noradrenergic system by intracoerulear microinfusion of corticotropin-releasing factor: effects on discharge rate, cortical norepinephrine levels and cortical electroencephalographic activity. J. Pharmacol. Exp. Ther. 281 1 (1997) 163-172
8. Curtis A.L., Pavcovich L.A., and Valentino R.J. Long-term regulation of locus ceruleus sensitivity to corticotropin-releasing factor by swim stress. J. Pharmacol. Exp. Ther. 289 3 (1999) 1211-1219
9. Curtis A.L., Bello N.T., and Valentino R.J. Evidence for functional release of endogenous opioids in the locus ceruleus during stress termination. J. Neurosci. 21 13 (2001) RC152
10. Dailly E., Hascoet M., Colombel M.C., Jolliet P., and Bourin M. Relationship between cerebral pharmacokinetics and anxiolytic activity of diazepam and its active metabolites after a single intra-peritoneal administration of diazepam in mice. Hum. Psychopharmacol. 17 5 (2002) 239-245
11. Deak T., Nguyen K.T., Ehrlich A.L., Watkins L.R., Spencer R.L., Maier S.F., Licinio J., Wong M.L., Chrousos G.P., Webster E., and Gold P.W. The impact of the nonpeptide corticotropin-releasing hormone antagonist antalarmin on behavioral and endocrine responses to stress. Endocrinology 140 1 (1999) 79-86
12. De Boer S.F., and Koolhaas J.M. Defensive burying in rodents: ethology, neurobiology and psychopharmacology. Eur. J. Pharmacol. 463 1-3 (2003) 145-161
13. Fallon B.A., and Mathew S.J. Biological therapies for obsessive-compulsive disorder. J. Psychiatr. Pract. 6 3 (2000) 113-128
14. File S.E., and Gonzalez L.E. Anxiolytic effects in the plus-maze of 5-HT1A-receptor ligands in dorsal raphe and ventral hippocampus. Pharmacol. Biochem. Behav. 54 1 (1996) 123-128
15. Gomez F., Houshyar H., and Dallman M.F. Marked regulatory shifts in gonadal, adrenal, and metabolic system responses to repeated restraint stress occur within a 3-week period in pubertal male rats. Endocrinology 143 8 (2002) 2852-2862
16. Gutman D.A., Owens M.J., Skelton K.H., Thrivikraman K.V., and Nemeroff C.B. The corticotropin-releasing factor1 receptor antagonist R121919 attenuates the behavioral and endocrine responses to stress. J. Pharmacol. Exp. Ther. 304 2 (2003) 874-880
17. Harris R.B., Zhou J., Shi M., Redmann S., Mynatt R.L., and Ryan D.H. Overexpression of agouti protein and stress responsiveness in mice. Physiol. Behav. 73 4 (2001) 599-608
18. Harris R.B., Mitchell T.D., Simpson J., Redmann Jr. S.M., Youngblood B.D., and Ryan D.H. Weight loss in rats exposed to repeated acute restraint stress is independent of energy or leptin status. Am. J. Physiol.: Regul., Integr. Comp. Physiol. 282 1 (2002) R77-R88
19. Harris R.B., Zhou J., Mitchell T., Hebert S., and Ryan D.H. Rats fed only during the light period are resistant to stress-induced weight loss. Physiol. Behav. 76 4-5 (2002) 543-550
20. Harris R.B., Gu H., Mitchell T.D., Endale L., Russo M., and Ryan D.H. Increased glucocorticoid response to a novel stress in rats that have been restrained. Physiol. Behav. 81 4 (2004) 557-568
21. Harris R.B., Palmondon J., Leshin S., Flatt W.P., and Richard D. Chronic disruption of body weight but not of stress peptides or receptors in rats exposed to repeated restraint stress. Horm. Behav. 49 5 (2006) 615-625
22. Hogg S. A review of the validity and variability of the elevated plus-maze as an animal model of anxiety. Pharmacol. Biochem. Behav. 54 1 (1996) 21-30
23. Ichimaru Y., Egawa T., and Sawa A. 5-HT1A-receptor subtype mediates the effect of fluvoxamine, a selective serotonin reuptake inhibitor, on marble-burying behavior in mice. Jpn. J. Pharmacol. 68 1 (1995) 65-70
24. Jones B.J., Costall B., Domeney A.M., Kelly M.E., Naylor R.J., Oakley N.R., and Tyers M.B. The potential anxiolytic activity of GR38032F, a 5-HT3-receptor antagonist. Br. J. Pharmacol. 93 4 (1988) 985-993
25. Koolhaas J.M., Korte S.M., De Boer S.F., Van Der Vegt B.J., Van Reenen C.G., Hopster H., De Jong I.C., Ruis M.A., and Blokhuis H.J. Coping styles in animals: current status in behavior and stress-physiology. Neurosci. Biobehav. Rev. 23 7 (1999) 925-935
26. MacNeil G., Sela Y., McIntosh J., and Zacharko R.M. Anxiogenic behavior in the light-dark paradigm follwoing intraventricular administration of cholecystokinin-8S, restraint stress, or uncontrollable footshock in the CD-1 mouse. Pharmacol. Biochem. Behav. 58 3 (1997) 737-746
27. Morilak D.A., Cecchi M., and Khoshbouei H. Interactions of norepinephrine and galanin in the central amygdala and lateral bed nucleus of the stria terminalis modulate the behavioral response to acute stress. Life Sci. 73 6 (2003) 715-726
28. Njung'e K., and Handley S.L. Evaluation of marble-burying behavior as a model of anxiety. Pharmacol. Biochem. Behav. 38 1 (1991) 63-67
29. Onaivi E.S., and Martin B.R. Neuropharmacological and physiological validation of a computer-controlled two-compartment black and white box for the assessment of anxiety. Prog. Neuro-Psychopharmacol. Biol. Psychiatry 13 6 (1989) 963-976
30. Pinel J.P., Mumby D.G., Dastur F.N., and Pinel J.G. Rat (Rattus norvegicus) defensive behavior in total darkness: risk-assessment function of defensive burying. J. Comp. Psychol. 108 2 (1994) 140-147
31. Servatius R.J., Ottenweller J.E., Bergen M.T., Soldan S., and Natelson B.H. Persistent stress-induced sensitization of adrenocortical and startle responses. Physiol. Behav. 56 5 (1994) 945-954
32. Smagin G.N., Harris R.B., and Ryan D.H. Corticotropin-releasing factor receptor antagonist infused into the locus coeruleus attenuates immobilization stress-induced defensive withdrawal in rats. Neurosci. Lett. 220 3 (1996) 167-170
33. Takeuchi H., Yatsugi S., and Yamaguchi T. Effect of YM992, a novel antidepressant with selective serotonin re-uptake inhibitory and 5-HT 2A receptor antagonistic activity, on a marble-burying behavior test as an obsessive-compulsive disorder model. Jpn. J. Pharmacol. 90 2 (2002) 197-200
34. Timpl P., Spanagel R., Sillaber I., Kresse A., Reul J.M., Stalla G.K., Blanquet V., Steckler T., Holsboer F., and Wurst W. Impaired stress response and reduced anxiety in mice lacking a functional corticotropin-releasing hormone receptor 1. Nat. Genet. 19 2 (1998) 162-166
35. Treit D., Pesold C., and Rotzinger S. Dissociating the anti-fear effects of septal and amygdaloid lesions using two pharmacologically validated models of rat anxiety. Behav. Neurosci. 107 5 (1993) 770-785
36. Valentino R.J., and Van Bockstaele E. Opposing regulation of the locus coeruleus by corticotropin-releasing factor and opioids. Potential for reciprocal interactions between stress and opioid sensitivity. Psychopharmacology (Berlin) 158 4 (2001) 331-342
37. Van Bockstaele E.J., Colago E.E., and Valentino R.J. Corticotropin-releasing factor-containing axon terminals synapse onto catecholamine dendrites and may presynaptically modulate other afferents in the rostral pole of the nucleus locus coeruleus in the rat brain. J. Comp. Neurol. 364 3 (1996) 523-534
38. Van Dijken H.H., Van der Heyden J.A., Mos J., and Tilders F.J. Inescapable footshocks induce progressive and long-lasting behavioural changes in male rats. Physiol. Behav. 51 4 (1992) 787-794
39. Vernikos J., Dallman M.F., Bonner C., Katzen A., and Shinsako J. Pituitary-adrenal function in rats chronically exposed to cold. Endocrinology 110 2 (1982) 413-420